Shawn P. Cain
Directeur des opérations chez Lyophilization Services of New England, Inc.
Profil
Shawn P.
Cain is a professional with experience in various firms.
Currently, he is the Chief Operating Officer at Lyophilization Services of New England, Inc. Previously, he worked as the President & Chief Executive Officer at Arbios Systems, Inc., Director-Facilities & Engineering at Organogenesis, Inc., Director-Product Development at HepaLife Technologies, Inc., Operations Director at Formatech, Inc., and Vice President-Operations at CB Biomedical, Inc. He completed his undergraduate degree at Northeastern University and his graduate degree at the University of Massachusetts.
Postes actifs de Shawn P. Cain
| Sociétés | Poste | Début |
|---|---|---|
Lyophilization Services of New England, Inc.
 Lyophilization Services of New England, Inc. Medical SpecialtiesHealth Technology Lyophilization Services of New England, Inc. provides contract lyophilization services to the pharmaceutical, biotechnology, and medical device industries. The firm offers analytical method development, formulation and lyophilization cycle development and optimization, cGMP aseptic fill finish (liquid or lyophilization), and bulk lyophilization. The company was founded by Matthew J. Halvorsen in 1997 and is headquartered in Bedford, NH. | Directeur des opérations | 01/01/2012 |
Anciens postes connus de Shawn P. Cain
| Sociétés | Poste | Fin |
|---|---|---|
Formatech, Inc.
 Formatech, Inc. Pharmaceuticals: MajorHealth Technology Formatech, Inc. develops and manufactures therapeutic products. The firm specializes in contract research & development and aseptic contract manufacturing. It also offers liquid fills, lyophilization, compounding, and development services. The company was founded by Benjamin S. Isaacs in 1993 and is headquartered in Andover, MA. | Directeur des opérations | - |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Directeur Technique/Scientifique/R&D | - |
HepaLife Technologies, Inc.
 HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Corporate Officer/Principal | - |
CB Biomedical, Inc.
 CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Directeur des opérations | - |
| ARBIOS SYSTEMS, INC. | Directeur Général | - |
Formation de Shawn P. Cain
| Northeastern University | Undergraduate Degree |
| University of Massachusetts | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
CB Biomedical, Inc.
CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Commercial Services |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
Arbios Systems, Inc.
 Arbios Systems, Inc. Medical SpecialtiesHealth Technology Arbios Systems, Inc. engages in the development, manufacture, and marketing of liver assist therapies for medical treatment of liver failure. The company was founded by Achilles A. Demetriou and Jacek Rozga in February 1999 and is headquartered in Allendale, NJ. | Health Technology |
Lyophilization Services of New England, Inc.
Lyophilization Services of New England, Inc. Medical SpecialtiesHealth Technology Lyophilization Services of New England, Inc. provides contract lyophilization services to the pharmaceutical, biotechnology, and medical device industries. The firm offers analytical method development, formulation and lyophilization cycle development and optimization, cGMP aseptic fill finish (liquid or lyophilization), and bulk lyophilization. The company was founded by Matthew J. Halvorsen in 1997 and is headquartered in Bedford, NH. | Health Technology |
Formatech, Inc.
Formatech, Inc. Pharmaceuticals: MajorHealth Technology Formatech, Inc. develops and manufactures therapeutic products. The firm specializes in contract research & development and aseptic contract manufacturing. It also offers liquid fills, lyophilization, compounding, and development services. The company was founded by Benjamin S. Isaacs in 1993 and is headquartered in Andover, MA. | Health Technology |
